Sorbent Therapeutics Secures $6,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=19db2039-a9c7-4e3c-bcf0-63bc608aedce&Preview=1 -
Date
6/11/2012 -
Company Name
Sorbent Therapeutics -
Mailing Address
710 Lakeway Drive Sunnyvale, CA 94085 -
Company Description
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension. -
Website
http://www.sorbentrx.com -
Transaction Type
Debt -
Transaction Amount
$6,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
